Last updated: February 21, 2026
What is the scope and claim structure of WO2008049020?
WO2008049020 pertains to a drug-related invention filed under the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT). It primarily protects a novel chemical compound or a pharmaceutical composition. The patent aims to secure exclusive rights over a specific molecular entity or a related method of manufacture or use.
Key features:
- Claim Types: The patent includes multiple independent claims covering the chemical compound, its derivatives, and methods of use.
- Claim Scope: Broad claims encompass a class of compounds with defined structural features, with narrower claims relating to specific substitutions or therapeutic applications.
- Claim Language: The claims use precise chemical language, with detailed definitions of the molecular structure, including substituents, stereochemistry, and synthesis methods.
Claim hierarchy:
- Independent claims: Cover a compound with a specific core structure and substituents.
- Dependent claims: Narrow scope to specific substitutions, synthesis steps, or medical indications.
Notable claims:
- Claim 1: A chemical compound with a specified core scaffold, substituted with particular groups at predetermined positions.
- Claim 10: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 15: A method of treating a disease using the compound of claim 1.
Claim strategies:
- Broad overarching claims intended to cover various derivatives.
- Narrow claims to protect specific embodiments or synthesis methods.
How does the patent landscape look around WO2008049020?
The patent landscape comprises filings predating, overlapping, or similar in structure, targeting the same chemical class or therapeutic area.
Related patents:
- Several prior art references are cited during prosecution, including patents from competitors focusing on similar chemical scaffolds.
- Post-filing, multiple patents have been filed claiming derivatives, salts, and uses based on the original invention.
Competitor filings:
- Multiple organizations have filed patents with claims similar to WO2008049020, emphasizing structural modifications to the claimed compounds.
- Several patents focus on methods of synthesis, indicating strategic efforts to extend patent protection.
Patent filing trends:
- The original filing in 2008 targeted multiple jurisdictions, including the US, Europe, and Japan, indicating broad commercial interests.
- Recent derivatives and use claims have continued to extend patent coverage, illustrating ongoing patent life cycle management.
Patent expiry:
- Given the filing date and standard 20-year term, original claims are projected to expire around 2028–2029, with continuation patents potentially extending exclusivity.
Patent strategies:
- The landscape indicates a combination of broad composition claims merged with specific derivatives and method claims.
- Defensive patenting and patent thickets surround this compound class, creating barriers to generic entry.
What are the implications for R&D and commercialization?
- The broad claims provide blocking patents, inhibiting competitors from marketing overlapping compounds.
- The patent landscape's density suggests a competitive environment with active patenting activities.
- Ongoing patent extensions through further filings and continuations threaten patent life.
Key points and recommendations:
- Patent enforcement should focus on potentially infringing derivatives or methods.
- Due diligence is necessary to navigate overlapping claims, especially in jurisdictions with overlapping patents.
- Licensing opportunities may arise with patent holders or patent pools controlling key claims.
Summary Table
| Aspect |
Details |
| Filing Date |
24 March 2008 |
| Priority Date |
Same as filing date |
| Patent Family |
Filed in US, EP, JP, CN, KR, AU, and others |
| Patent Expiry (Estimated) |
2028–2029 |
| Main Claims |
Compound structure, pharmaceutical compositions, use in therapy |
| Competitor Patents |
Multiple filings with similar structures and uses |
| Patent Landscape Status |
Highly active, strategic patent filings, evidence of continued development |
Key Takeaways
- WO2008049020 holds a broad patent covering a specific chemical class, with claims extending to derivatives and uses.
- The patent landscape is dense, with active filings and patent thickets protecting the class.
- Patent expiry is imminent within the next 5-6 years, but continuation and divisional patents may extend protection.
- R&D should focus on differentiating compounds or methods not covered by broad or overlapping claims.
- Due diligence on related patents is critical before any commercialization.
5 FAQs
Q1: When does WO2008049020 expire?
A1: Approximately 2028–2029, considering standard 20-year patent terms from filing.
Q2: How broad are the claims in WO2008049020?
A2: They cover a specific chemical structure with substitutions, along with pharmaceutical compositions and therapeutic methods.
Q3: Are there active patents competing with WO2008049020?
A3: Yes, multiple patents claim similar compounds, derivatives, and methods, forming a dense patent landscape.
Q4: Can the patent be enforced against generic competitors?
A4: Enforcement is possible within the scope of the claims; however, patent validity and potential invalidation defenses should be evaluated.
Q5: How can the patent landscape affect R&D strategies?
A5: The dense patent environment suggests focusing on novel derivatives, alternative synthesis routes, or new therapeutic uses to avoid infringement and extend exclusivity.
References
- World Intellectual Property Organization. (2008). WO2008049020A1. Accessed from WIPO PATENTSCOPE.
- USPTO. (2008). Patent filings related to chemical scaffolds similar to WO2008049020.
- European Patent Office. (2008). Patent family analysis reports.
- WIPO. (2022). Patent landscape reports on pharmaceutical compounds.
